Pancreatic Cancer Research

ResearcherEmory UniversityActive in the last 2 years

Pelin Bağcı

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6656-8227; OpenAlex author ID A5042273117. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 7

  1. "Simple Mucinous Cysts" associated with pancreatic ductal adenocarcinoma: clinicopathologic and radiologic characterization of an enigmatic cyst and additional… Co-author DOI 10.1007/s00428-026-04705-w↗
  2. "Horses out of the barn": pancreatic ductal adenocarcinoma frequently extends beyond the grossly visible tumour, requiring microscopic rectification for accura… Co-author DOI 10.1111/his.70099↗
  3. The Importance of Stroma and Stromal SMA Expression in Pancreatic Ductal Adenocarcinoma. First author DOI 10.5146/tjpath.2024.13521↗
  4. Prognostic Value of Tissue-Resident Memory T Cells and Tumor Microenvironmental Features in Resected Pancreatic Adenocarcinoma Co-author DOI 10.5152/balkanmedj.2021.21122↗
  5. Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Editio… Co-author DOI 10.1245/s10434-016-5093-7↗
  6. Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TN… Co-author DOI 10.1245/s10434-015-4861-0↗
  7. Histopathologic assessment of pancreatic cancer: does one size fit all? First author DOI 10.1002/jso.23194↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Volkan N. Adsay · 5 shared papers, 2013–2026 · strength 0.64
  2. Michelle Dian Reid · 5 shared papers, 2013–2026 · strength 0.64
  3. Olca Baştürk · 4 shared papers, 2015–2026 · strength 0.57
  4. Burcu Saka · 4 shared papers, 2015–2026 · strength 0.57
  5. Gamze Akbaş · 1 shared paper, 2024 · strength 0.46
  6. David A. Kooby · 3 shared papers, 2015–2026 · strength 0.33
  7. Juan Manuel Sarmiento · 3 shared papers, 2015–2026 · strength 0.33
  8. Alyssa M. Krasinskas · 3 shared papers, 2015–2026 · strength 0.33
  9. Shishir Kumar Maithel · 3 shared papers, 2015–2026 · strength 0.33
  10. Bassel F. El‐Rayes · 3 shared papers, 2015–2026 · strength 0.33
  11. Cisel A. Mericoz · 1 shared paper, 2026 · strength 0.24
  12. Nuray Tezcan · 1 shared paper, 2026 · strength 0.24
  13. Perran Fulden Yumuk · 1 shared paper, 2022 · strength 0.14
  14. Tuğba Başoğlu Tüylü · 1 shared paper, 2022 · strength 0.14
  15. Lauren McLendon Postlewait · 2 shared papers, 2015–2016 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.